pacDNA
PrivateLast Round
Grant
Jan 17, 2025
Total Funding Raised
$2.99M
Company Overview
pacDNA is a biotechnology company that develops oligonucleotide therapeutics for the treatment of cancer and rare genetic disorders.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Precision Medicine
Business Model
B2B
Customer Profile
Revenue Share, Services & Consulting, Government Contracts
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
pacDNA Comparables
Compare pacDNA with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Entos Pharmaceuticals | 75% | |
| PepGen | 72% | |
| Avidity Biosciences | 68% | |
pacDNA Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Grant | Jan 17, 2025 | ||||
| Grant | Sep 1, 2023 | ||||
| Grant | Dec 1, 2022 | ||||
| Accelerator | Sep 1, 2022 | ||||
| Grant | Jul 1, 2022 |
pacDNA Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| NIH RADx | Grant |
| Congressionally Directed Medical Research Programs | Grant |
| Northeastern University Center for Research Innovation | Grant |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jan 17, 2025
$490K grant from Congressionally Directed Medical Research Programs
- Sep 1, 2023
$50K grant received from Northeastern University Center for Research Innovation.
pacDNA Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about pacDNA's valuation, stock price, and market status.